Johnson & Johnson Announces Executive Appointments: Sheri McCoy, Worldwide Chairman, Pharmaceuticals Group, and Alex Gorsky, Wor
October 09 2008 - 10:15AM
PR Newswire (US)
NEW BRUNSWICK, N.J., Oct. 9 /PRNewswire-FirstCall/ -- Johnson &
Johnson today announced that Sheri McCoy, currently Worldwide
Chairman, Surgical Care Group, has been appointed Worldwide
Chairman, Pharmaceuticals Group, effective January 1, 2009. In this
role, Ms. McCoy succeeds Christine Poon, who last month announced
plans to retire from the Company on March 1, 2009. Alex Gorsky,
currently Company Group Chairman and Worldwide Franchise Chairman,
Ethicon, Inc., will assume the role of Worldwide Chairman, Surgical
Care Group, effective January 1, 2009, and become a member of the
Executive Committee. "Sheri and Alex are proven leaders in driving
high performance and developing talent across multiple business
segments," said Johnson & Johnson Chairman and Chief Executive
Officer William C. Weldon. "These appointments allow for a smooth
transition of responsibilities within our senior leadership team."
In being appointed earlier this year to the newly created position
of Worldwide Chairman, Surgical Care Group, Ms. McCoy's
responsibilities included the surgical franchises Ethicon, Ethicon
Endo-Surgery and DePuy, as well as medical devices and diagnostics
organizations in the Latin America, Europe/Middle East/Africa and
Asia Pacific regions. She also became a member of the Executive
Committee. Ms. McCoy, 49, joined Johnson & Johnson in 1982 as
an associate scientist in Research and Development at what was then
the Personal Products Company, and held positions of increasing
responsibility within the R&D organization. She was named
Global President of the Baby and Wound Care franchises in 2002 and
held that role until 2005, when she was named Company Group
Chairman and Worldwide Franchise Chairman for Ethicon and the
Medical Devices & Diagnostics business in Latin America.
"Sheri's strong research background and breadth of experience have
prepared her well to assume the leadership of our Pharmaceuticals
Group," Weldon said. Mr. Gorsky, 48, joined Ethicon early this year
as Company Group Chairman and Worldwide Franchise Chairman. Until
2004, he was Company Group Chairman for Johnson & Johnson's
pharmaceuticals business in EMEA. Earlier, he served as President
of Janssen Pharmaceutica Inc. in the United States after spending
15 years in various sales, marketing and management roles. In 2004,
Mr. Gorsky joined the Novartis Pharmaceuticals Corporation and was
head of the North American pharmaceuticals business. Weldon said,
"Throughout a long career at Johnson & Johnson, Alex has
demonstrated success in both the pharmaceutical and surgical care
aspects of our business." About Johnson & Johnson Caring for
the world, one person at a time ... inspires and unites the people
of Johnson & Johnson. We embrace research and science --
bringing innovative ideas, products and services to advance the
health and well-being of people. Our 120,200 employees at more than
250 Johnson & Johnson companies work with partners in health
care to touch the lives of over a billion people every day,
throughout the world. DATASOURCE: Johnson & Johnson CONTACT:
Media, Bill Price, +1-732-524-6623, or Jeffrey J. Leebaw,
+1-732-524-3350, or Investors, Louise Mehrotra, +1-732-524-6491, or
Lesley Fishman, +1-732-524-3922, or Stan Panasewicz,
+1-732-524-2524, or Tina Pinto, +1-732-524-2034, all of Johnson
& Johnson Web Site: http://www.jnj.com/
Copyright